Streetbeat News

Price Targets

MU

NVDA

Micron Technology Inc (NASDAQ:MU) shares rose after reporting better-than-expected Q1 revenues. Analysts are optimistic, citing strong pricing rebound in DRAM and NAND, with most raising their price targets. Micron's gross margin and earnings outlook exceeded expectations, and inventory levels are normalizing. The company's HBM3E product is expected to drive demand, particularly with NVIDIA Corp (NASDAQ:NVDA) for its H200 and GH200 offerings. Analysts predict a memory cycle upswing, supported by disciplined supply management and strong AI-driven demand.

Portfolio Pulse from Priya Nigam

December 21, 2023 | 5:18 pm

CNSWF

BMO Capital analyst Thanos Moschopoulos has maintained an Outperform rating on Constellation Software and increased the price target from C$3350 to C$3600.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 5:03 pm

UPS

Analysts have provided mixed ratings for United Parcel Service (NYSE:UPS) with 1 bullish and 5 indifferent. The average 12-month price target is now $173.17, down from $181.80. Analysts from firms including JP Morgan, Susquehanna, Raymond James, HSBC, and Barclays have adjusted their price targets and ratings, reflecting a cautious outlook on UPS's performance. Despite a revenue decline of -12.83% over the past 3 months, UPS maintains strong financial health indicators such as a net margin of 5.35%, ROE of 5.75%, and ROA of 1.6%, with a debt-to-equity ratio of 1.33.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 5:01 pm

BROS

Dutch Bros (NYSE:BROS) received mixed analyst ratings with an average 12-month price target of $32.8, reflecting a slight increase from the previous target of $32.60. Analysts from Wedbush and JP Morgan raised their price targets, while Barclays lowered theirs. The company's financial performance shows strong revenue growth but below-average profitability and efficiency metrics. Dutch Bros's market capitalization is below the industry average, and it has a lower reliance on debt financing.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 5:00 pm

EOG

Raymond James has reaffirmed its Strong Buy rating on EOG Resources (NYSE:EOG) but reduced its price target from $154.00 to $148.00. EOG Resources' shares are slightly down, trading at $121.35. The new price target suggests a potential upside of 21.96%. EOG Resources is a significant oil and gas producer with key operations in U.S. shale regions and reported substantial reserves and production in 2022.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 5:00 pm

SHW

Argus Research has reaffirmed its Buy rating on Sherwin-Williams (NYSE:SHW), increasing the price target from $330.00 to $378.00. Sherwin-Williams' current share price is $304.21, and the new price target suggests a potential upside of 24.26%. Sherwin-Williams is a leading architectural paint provider in the U.S., with over 4,900 stores.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 5:00 pm

BROS

Wedbush has reaffirmed its Outperform rating on Dutch Bros (NYSE:BROS) and increased its price target from $35.00 to $37.00. Dutch Bros' shares have risen 2.55% in the last 24 hours to $29.37. The new price target suggests a potential upside of 25.98% from the current price. Dutch Bros operates and franchises drive-thru coffee shops offering a variety of hand-crafted beverages.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 5:00 pm

LQDA

B of A Securities has reaffirmed its Buy rating on Liquidia (NASDAQ:LQDA) and increased its price target from $13.00 to $15.00. Liquidia's shares have risen 3.46% in the last 24 hours to $11.07. The new price target suggests a potential upside of 35.5%. Liquidia is a biopharmaceutical company focusing on pulmonary hypertension treatments, utilizing its proprietary PRINT technology.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 5:00 pm

UPS

JP Morgan has maintained a Neutral rating for United Parcel Service (UPS) but lowered its price target from $165.00 to $156.00. UPS shares are currently trading down 0.22% at $156.61, and a move to the new target would imply a 0.39% decrease. UPS is the world's largest parcel delivery company, with significant operations in the U.S. and internationally.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 5:00 pm

BMRN

Biomarin Pharmaceutical (NASDAQ:BMRN) has been evaluated by 10 analysts over the last three months, with a mix of bullish and bearish sentiments. The average 12-month price target is $108.6, down from $116.17, with a high estimate of $140.00 and a low of $82.00. Analysts from firms including Stifel, RBC Capital, BMO Capital, Piper Sandler, Morgan Stanley, Barclays, Cantor Fitzgerald, Bernstein, and Truist Securities have provided ratings and price target updates, reflecting changes in market conditions and company performance. BioMarin focuses on rare-disease therapies and has seen a revenue growth of 15.04% as of September 30, 2023, but lags behind industry peers. The company has a strong net margin of 6.95%, ROE of 0.83%, ROA of 0.61%, and a low debt-to-equity ratio of 0.22.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 5:00 pm